BlackRock Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$164M Sell
3,001,274
-1,038,282
-26% -$59M 0.19% 106
2016
Q3
$265M Buy
4,039,556
+436,038
+12% +$28.5M 0.33% 57
2016
Q2
$218M Buy
3,603,518
+1,523,134
+73% +$88.5M 0.28% 77
2016
Q1
$117M Buy
2,080,384
+219,022
+12% +$13.2M 0.15% 137
2015
Q4
$126M Sell
1,861,362
-404,044
-18% -$26.5M 0.16% 126
2015
Q3
$144M Buy
2,265,406
+95,148
+4% +$6.26M 0.2% 108
2015
Q2
$138M Buy
2,170,258
+476,823
+28% +$32.6M 0.17% 122
2015
Q1
$116M Buy
1,693,435
+38,280
+2% +$2.66M 0.15% 144
2014
Q4
$116M Buy
1,655,155
+685,058
+71% +$49.1M 0.15% 145
2014
Q3
$69.3M Buy
970,097
+445,770
+85% +$32.6M 0.1% 203
2014
Q2
$39M Sell
524,327
-938,248
-64% -$67.8M 0.05% 333
2014
Q1
$94.9M Buy
1,462,575
+101,367
+7% +$6.55M 0.14% 157
2013
Q4
$80.8M Buy
1,361,208
+570,556
+72% +$31M 0.12% 180
2013
Q3
$41.1M Buy
790,652
+143,790
+22% +$7.22M 0.07% 266
2013
Q2
$30.6M Buy
+646,862
New +$32.9M 0.05% 319

Other funds holding AZN